"Objective: The aim of this study was to evaluate the efficacy and safety of the mesenchymal stem cell (MSC) therapy in patients with ischemic stroke (IS). Materials and methods: Clinical trials involved…
Cellf is a new and innovative company based around delivering the latest technology in complementary medicine for rejuvenation of cell damage.
Email:
Disclaimer: When accessing the material in this website it is advised that you seek Physician advise before making any conclusions. The website contains the opinions of multiple authors and is intended for educational purposes only with the understanding the website is not providing any professional services.
© Copyright Cellf 2024
SEO Perth by 3am Ideas